Chemotherapy treatment in malignant pleural mesothelioma: a difficult history.

about

Chemotherapy treatment in malignant pleural mesothelioma: a difficult history.

Item

http://www.wikidata.org/entity/Q52672893

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Chemotherapy treatment in malignant pleural mesothelioma: a difficult history.

@en

Chemotherapy treatment in malignant pleural mesothelioma: a difficult history.

@nl

type

Item

label

Chemotherapy treatment in malignant pleural mesothelioma: a difficult history.

@en

Chemotherapy treatment in malignant pleural mesothelioma: a difficult history.

@nl

prefLabel

Chemotherapy treatment in malignant pleural mesothelioma: a difficult history.

@en

Chemotherapy treatment in malignant pleural mesothelioma: a difficult history.

@nl

P1476

Chemotherapy treatment in malignant pleural mesothelioma: a difficult history.

@en

P2093

Andrea Ardizzoni

http://www.w3.org/2001/XMLSchema#string

Barbara Melotti

http://www.w3.org/2001/XMLSchema#string

Francesca Sperandi

http://www.w3.org/2001/XMLSchema#string

Karim Rihawi

http://www.w3.org/2001/XMLSchema#string

Marika Cinausero

http://www.w3.org/2001/XMLSchema#string

P2860

Modern management of malignant pleural mesothelioma

Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment.

Combination of raltitrexed and oxaliplatin is an active regimen in malignant mesothelioma: results of a phase II study.

Cisplatin and gemcitabine treatment for malignant mesothelioma: a phase II study.

Phase II trial of ZD0473 as second-line therapy in mesothelioma.

Gemcitabine combined with carboplatin in patients with malignant pleural mesothelioma: a multicentric phase II study.

Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials.

Novel systemic therapy against malignant pleural mesothelioma.

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.

Pemetrexed plus cisplatin or pemetrexed plus carboplatin for chemonaïve patients with malignant pleural mesothelioma: results of the International Expanded Access Program.

P304

S304-S310

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21037/JTD.2017.10.19

http://www.w3.org/2001/XMLSchema#string

P433

Suppl 2

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29507800

http://www.w3.org/2001/XMLSchema#string

P932

5830568

http://www.w3.org/2001/XMLSchema#string